Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19

ABSTRACTAlthough severe coronavirus disease 2019 (COVID-19) and hospitalization associated with COVID-19 are generally preventable among healthy vaccine recipients, patients with immunosuppression have poor immunogenic responses to COVID-19 vaccines and remain at high risk of infection with SARS-CoV...

Cijeli opis

Bibliografski detalji

Glavni autori:	Juan G. Ripoll, Sidna M. Tulledge-Scheitel, Anthony A. Stephenson, Shane Ford, Marsha L. Pike, Ellen K. Gorman, Sara N. Hanson, Justin E. Juskewitch, Alex J. Miller, Solomiia Zaremba, Erik A. Ovrom, Raymund R. Razonable, Ravindra Ganesh, Ryan T. Hurt, Erin N. Fischer, Amber N. Derr, Michele R. Eberle, Jennifer J. Larsen, Christina M. Carney, Elitza S. Theel, Sameer A. Parikh, Neil E. Kay, Michael J. Joyner, Jonathon W. Senefeld
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology 2024-05-01
Serija:	mBio
Teme:	antibody therapy SARS-CoV-2 immunocompromised hosts
Online pristup:	https://journals.asm.org/doi/10.1128/mbio.00400-24
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!